Search

everythinglearnresearchcommunity

for

Search:↓

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

HDR electronic brachytherapy effectively treats nonmelanoma skin cancer with good cosmetic results and minimal side effects.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Some breast cancer chemotherapy can cause permanent hair loss.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Curcumin may improve cancer radiotherapy by making cancer cells more sensitive to radiation and protecting normal cells.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Hair from breast cancer patients shows changes in structure and composition, and a test using these changes detected cancer but also falsely identified some healthy samples as cancerous.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Tryptanthrin effectively suppresses non-melanoma skin cancer and is safe for normal skin.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Natural products can help overcome cancer drug resistance.

Curcumin may be an effective and safer anticancer agent by regulating key cell pathways.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.

Liposomes show promise in cancer treatment by delivering drugs with less toxicity and improved effectiveness.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Lack of functional CYLD in mice leads to early aging and cancer.

Dermocosmetics help manage skin issues in cancer patients, improving outcomes and reducing treatment interruptions.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Rare adrenal cancers that secrete androgens or estrogens have a poor prognosis and are treated primarily with surgery.

Resistance exercise improves body image in breast cancer survivors.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.